Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation.

MLA

Saisana, Marina, et al. “Importance of the Type I Insulin-like Growth Factor Receptor in HER2, FGFR2 and MET-Unamplified Gastric Cancer with and without Ras Pathway Activation.” Oncotarget, vol. 7, no. 34, Aug. 2016, pp. 54445–62. EBSCOhost, https://doi.org/10.18632/oncotarget.10642.

APA

Saisana, M., Griffin, S. M., & May, F. E. B. (2016). Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation. Oncotarget, 7(34), 54445–54462. https://doi.org/10.18632/oncotarget.10642

Chicago

Saisana, Marina, S Michael Griffin, and Felicity E B May. 2016. “Importance of the Type I Insulin-like Growth Factor Receptor in HER2, FGFR2 and MET-Unamplified Gastric Cancer with and without Ras Pathway Activation.” Oncotarget 7 (34): 54445–62. doi:10.18632/oncotarget.10642.